Relative Bioavailability of ESK-001 Tablet Versus Liquid in Healthy Participants

Clinical trial NCT05330858 · COMPLETED

Trial details

NCT number: NCT05330858
Sponsor: Alumis Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmacokinetics

Start date: 2022-03-17
Primary completion: 2022-06-30
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.